Log in to your Inderes Free account to see all free content on this page.
Duearity
0.381 SEK 0%1 investor is following this company
Duearity operates in the medical technology industry. The company specializes in the development and production of technical solutions for the treatment and relief of tinnitus. The product portfolio includes, for example, the company's proprietary products Tinearity and Duearity. In addition to the main business, service and associated ancillary services are also offered. Duearity operates on the Swedish market.
Revenue
970K
EBIT %
-2,135.05 %
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
First North Stockholm
DEAR
Daily low / high price
0.38 / 0.41
SEK
Market cap
10.02M SEK
Turnover
5.27K SEK
Volume
14K
Latest videos
Financial calendar
Interim report
16.05.2024
General meeting
03.06.2024
Interim report
22.08.2024
Interim report
28.11.2024
Annual report
27.02.2025
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Footloose Invest AB | 33.7 % | 33.7 % |
JeGol Group AB | 13.7 % | 13.7 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
Clinics in the US can now purchase Tinearity G1 through a national trading platform
Eminova Partners day - Duearity
Join Inderes community
Don't miss out - create an account and get all the possible benefits
FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio